Megalabs
PrivateLast Round
Seed
Jun 27, 2024
Est. Valuation
$100M
Total Funding Raised
$160M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Megalabs is a pharmaceutical company that develops, manufactures, and commercializes therapeutic solutions, primarily serving the Latin American market.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Fashion & Beauty, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Megalabs Comparables
Compare Megalabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Grupo Bagó | 86% | |
| Laboratorios Roemmers | 83% | |
| Laboratorios Senosiain | 82% |
Megalabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 27, 2024 | ||||
| Debt | Feb 3, 2023 | ||||
| Debt | Dec 8, 2022 | ||||
| Buyout/LBO | Apr 24, 2018 |
Key People
Founding team and executive leadership
Megalabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDB Invest | Debt |
| Dragonfly Capital | Seed |
| Robot Ventures | Seed |
| Big Brain Holdings | Seed |
| Folius Ventures | Seed |
| Tangent Ventures | Seed |
| Credibly Neutral | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 41% MoM, reaching 57K.
- Jul 13, 2026
Open roles increased to 292, 18% of headcount.
Megalabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access